Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01942694 · ClinicalTrials.gov registry record · NA
Vitamin D and Type 2 Diabetes Study
A NA study of Type 2 Diabetes and PreDiabetes, sponsored by Tufts Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 2,423
- Enrollment target
- 20
- Study locations
NCT01942694 is a NA study of Type 2 Diabetes and PreDiabetes that has completed, run by Tufts Medical Center. The registered enrollment target is 2,423 participants, above the 1,094-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (121% higher). The trial reports 20 study locations across 16 states.
The verdict
NCT01942694, a NA study of Type 2 Diabetes and PreDiabetes, has completed, sponsored by Tufts Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,423 participants
- Enrollment target
- 20
- Study locations
Study Summary
The goal of the Vitamin D and type 2 diabetes (D2d) study is to determine if vitamin D supplementation works to delay the onset of type 2 diabetes in people at risk for the disease and to gain a better understand how vitamin D affects glucose (sugar) metabolism.
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Vitamin D (Cholecalciferol)
Study Locations (20)
California
- University of Southern California - Los Angeles
- Stanford University - Palo Alto
Florida
- Orlando VA Medical Center - Orlando
- Florida Hospital Translational Research Institute - Orlando
Louisiana
- Pennington Biomedical Research Center - Baton Rouge
- Tulane University Health Sciences - New Orleans
Nebraska
- Omaha VA Medical Center - Omaha
- University of Nebraska Medical Center - Omaha
Arizona
- Southwest American Indian Center - Phoenix
Colorado
- University of Colorado, Denver - Aurora
Georgia
- Atlanta VA Medical Center - Decatur
Illinois
- Northwestern University - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,423 participants |
| Start Date | 2013-10 |
| Est. Completion | 2018-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01942694
The ClinicalTrials.gov registry entry for NCT01942694 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 2,423 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,094-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target (121% higher). The listed sponsor is Tufts Medical Center, which has 169 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01942694 reports 20 study locations spanning 16 distinct geographic areas - top geographies include California, Florida, Louisiana.
Frequently Asked Questions
What is clinical trial NCT01942694 about?
NCT01942694 is a clinical study titled "Vitamin D and Type 2 Diabetes Study". The goal of the Vitamin D and type 2 diabetes (D2d) study is to determine if vitamin D supplementation works to delay the onset of type 2 diabetes in people at risk for the disease and to gain a better understand how vitamin D affects glucose (sugar) metabolism.
What is the current status of trial NCT01942694?
This trial is currently completed. It is a NA study. The enrollment target is 2,423 participants. The study started on 2013-10. Estimated completion is 2018-11.
What conditions does trial NCT01942694 study?
This clinical trial studies the following conditions: Type 2 Diabetes, PreDiabetes.
What interventions are being tested in trial NCT01942694?
The interventions under investigation include: Placebo (OTHER), Vitamin D (Cholecalciferol) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01942694?
This trial is sponsored by Tufts Medical Center, which has 169 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01942694 being conducted?
This trial has 20 study locations across Arizona, California, Colorado, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
A Randomized Double-Blinded and Placebo-Controlled Trial to Assess the Efficacy of Biophoton Therapy to Treat Type 2 Diabetes
RECRUITING · NA
-
High Fructose Diet, the Gut Microbiome, and Metabolic Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.